Monika Vainorius, MD

Trials

Studies that name Monika Vainorius, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:27 UTC. Open this list on ClinicalTrials.gov

• Ph1/Ph2
  NCT07900165 · Study of Varsetatug Masetecan in Combination With Anti-Cancer Therapies in Colorectal Cancer

  CytomX Therapeutics · not yet recruiting · Colo-rectal Cancer · study director
• Ph1
  NCT06462794 · First In Human Study of CX-801 in Advanced Solid Tumors

  CytomX Therapeutics · recruiting · Solid Tumor, Adult · study director
• Ph1
  NCT06265688 · First In Human Study of CX-2051 in Advanced Solid Tumors

  CytomX Therapeutics · recruiting · Solid Tumor, Adult · study director
• Ph1
  NCT04649112 · Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies

  Precision BioSciences, Inc. · completed · CD19 Expressing Malignancies, Hematologic Malignancy · study chair
• Ph1
  NCT04171843 · A Dose-escalation Study to Evaluate the Safety and Clinical Activity of PBCAR269A, With or Without Nirogacestat, in Study Participants With Relapsed/Refractory Multiple Myeloma

  Precision BioSciences, Inc. · terminated · Relapsed/Refractory Multiple Myeloma · study chair
• Ph1/Ph2
  NCT03149549 · PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

  CytomX Therapeutics · terminated · Solid Tumor, Adult, Breast Cancer, Non Small Cell Lung Cancer · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.